Total Payments
$80,948
2024 Payments
$12,552
Companies
48
Transactions
908
Medicare Patients
9,597
Medicare Billing
$1.2M
Payment Breakdown by Category
Other$44,360 (54.8%)
Food & Beverage$27,929 (34.5%)
Consulting$6,600 (8.2%)
Travel$1,822 (2.3%)
Education$236.77 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,360 | 30 | 54.8% |
| Food and Beverage | $27,929 | 839 | 34.5% |
| Consulting Fee | $6,600 | 3 | 8.2% |
| Travel and Lodging | $1,822 | 7 | 2.3% |
| Education | $236.77 | 29 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $58,248 | 184 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $3,968 | 132 | $0 (2024) |
| GlaxoSmithKline, LLC. | $3,650 | 77 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $2,523 | 71 | $0 (2024) |
| Amgen Inc. | $2,012 | 55 | $0 (2024) |
| ABBVIE INC. | $1,501 | 21 | $0 (2024) |
| Novo Nordisk Inc | $1,291 | 36 | $0 (2024) |
| Lilly USA, LLC | $1,149 | 45 | $0 (2024) |
| Amarin Pharma Inc. | $752.73 | 43 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $751.11 | 33 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $12,552 | 120 | Gilead Sciences, Inc. ($7,016) |
| 2023 | $6,482 | 92 | Gilead Sciences, Inc. ($3,496) |
| 2022 | $5,972 | 72 | Gilead Sciences, Inc. ($4,279) |
| 2021 | $7,099 | 109 | Gilead Sciences, Inc. ($4,319) |
| 2020 | $2,781 | 79 | Gilead Sciences, Inc. ($1,137) |
| 2019 | $13,403 | 153 | Gilead Sciences, Inc. ($10,670) |
| 2018 | $12,853 | 137 | Gilead Sciences, Inc. ($10,201) |
| 2017 | $19,805 | 146 | Gilead Sciences Inc ($17,130) |
All Payment Transactions
908 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: Diabetes | ||||||
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.94 | General |
| 12/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $120.87 | General |
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/26/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $150.00 | General |
| 11/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Diabetes | ||||||
| 11/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiology | ||||||
| 11/12/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
| 11/08/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAM | ||||||
| 11/08/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/07/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OS | ||||||
| 11/06/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: VACCINES | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.33 | General |
| Category: Biological | ||||||
| 10/24/2024 | Gilead Sciences, Inc. | Livdelzi (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: INFLAM | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.86 | General |
| Category: RESPIRATORY | ||||||
| 10/22/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $119.78 | General |
| Category: Respiratory | ||||||
| 10/16/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,331 | 2,327 | $275,455 | $141,835 |
| 2022 | 22 | 2,151 | 5,444 | $606,782 | $323,981 |
| 2021 | 30 | 2,843 | 6,505 | $622,408 | $346,044 |
| 2020 | 26 | 3,272 | 7,842 | $743,414 | $395,734 |
Total Patients
9,597
Total Services
22,118
Medicare Billing
$1.2M
Procedure Codes
102
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 191 | 519 | $75,831 | $36,616 | 48.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 147 | 354 | $73,225 | $36,577 | 50.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 93 | 93 | $19,530 | $13,855 | 70.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 158 | 185 | $24,766 | $12,942 | 52.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 119 | 226 | $20,650 | $8,636 | 41.8% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 17 | 127 | $10,222 | $5,404 | 52.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 27 | 27 | $7,390 | $5,160 | 69.8% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 14 | 87 | $8,964 | $3,904 | 43.6% |
| 99458 | Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | Office | 2023 | 13 | 74 | $4,839 | $2,687 | 55.5% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 46 | 71 | $4,714 | $2,472 | 52.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 84 | 84 | $2,502 | $1,812 | 72.4% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 53 | 53 | $2,259 | $1,596 | 70.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 21 | 21 | $2,587 | $1,511 | 58.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,001 | $1,401 | 46.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 17 | 19 | $2,801 | $1,341 | 47.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 38 | 38 | $1,900 | $1,333 | 70.2% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 30 | 30 | $2,081 | $1,300 | 62.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 92 | 107 | $2,188 | $898.80 | 41.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 67 | 68 | $2,380 | $807.91 | 33.9% |
| 90756 | Influenza vaccine, quadrivalent derived from cell cultures | Office | 2023 | 16 | 16 | $960.00 | $505.77 | 52.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 11 | 11 | $550.00 | $385.99 | 70.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 36 | 69 | $1,105 | $317.42 | 28.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 17 | 21 | $840.00 | $249.09 | 29.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 13 | 16 | $170.71 | $121.71 | 71.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 273 | 1,329 | $198,901 | $102,922 | 51.7% |
About Dr. Yanfeng Chen, M.D
Dr. Yanfeng Chen, M.D is a Internal Medicine healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1740280171.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yanfeng Chen, M.D has received a total of $80,948 in payments from pharmaceutical and medical device companies, with $12,552 received in 2024. These payments were reported across 908 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($44,360).
As a Medicare-enrolled provider, Chen has provided services to 9,597 Medicare beneficiaries, totaling 22,118 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Brooklyn, NY
- Active Since 07/28/2005
- Last Updated 08/16/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1740280171
Products in Payments
- Vemlidy (Drug) $45,080
- JARDIANCE (Drug) $1,932
- FARXIGA (Drug) $1,718
- AREXVY (Drug) $1,244
- BREZTRI (Drug) $1,095
- Prolia (Biological) $769.19
- Vascepa (Drug) $752.73
- SHINGRIX (Biological) $741.81
- XARELTO (Drug) $539.95
- EVENITY (Biological) $528.97
- Repatha (Biological) $515.65
- Ozempic (Drug) $461.36
- BREO (Drug) $457.36
- AIRSUPRA (Drug) $404.49
- ANORO (Drug) $393.49
- TRELEGY ELLIPTA (Drug) $391.34
- Humira (Biological) $364.20
- SYMBICORT (Drug) $319.05
- QULIPTA (Drug) $300.07
- VOQUEZNA (Drug) $275.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Brooklyn
Bruce Berger, M.d, M.D
Internal Medicine — Payments: $3.0M
Internal Medicine $3.0M
Dr. Jesi Ramone, Md, MD
Internal Medicine — Payments: $701,491
Internal Medicine $701,491
Dr. Ali El Atat, M.d, M.D
Internal Medicine — Payments: $426,309
Internal Medicine $426,309
Manish Parikh, Md, MD
Internal Medicine — Payments: $360,332
Internal Medicine $360,332
Dr. Samuel Uter, Md, MD
Internal Medicine — Payments: $238,375
Internal Medicine $238,375
Dr. Bharath Reddy, Md, MD
Internal Medicine — Payments: $159,733
Internal Medicine $159,733